[HTML] arvojournals.org

[HTML][HTML] The clinical phenotype of CNGA3-related achromatopsia: pretreatment characterization in preparation of a gene replacement therapy trial

D Zobor, A Werner, F Stanzial… - … & Visual Science, 2017 - tvst.arvojournals.org
Purpose: The purpose of this study was to clinically characterize patients with CNGA3-linked
achromatopsia (CNGA3-ACHM) in preparation of a gene therapy trial. Methods: Thirty-six …
被引用次数：56 相关文章
[PDF] annettewerner.com

[PDF][PDF] The Clinical Phenotype of CNGA3-Related Achromatopsia: Pretreatment Characterization in Preparation of a Gene Replacement Therapy Trial

D Zobor, A Werner, F Stanzial, F Benedicenti… - 2017 - annettewerner.com
PURPOSE. The purpose of this study was to clinically characterize patients with CNGA3-
linked achromatopsia (CNGA3-ACHM) in preparation of a gene therapy trial. METHODS …

[引用][C] The Clinical Phenotype of CNGA3-Related Achromatopsia: Pretreatment Characterization in Preparation of a Gene Replacement Therapy Trial

D Zobor, A Werner, F Stanzial… - … & Visual Science, 2017 - ub01.uni-tuebingen.de
The Clinical Phenotype of CNGA3-Related Achromatopsia: Pretreatment Characterization in
Preparation of a Gene Replacement Therapy Trial The Clinical Phenotype of CNGA3-Related …

The Clinical Phenotype of CNGA3-Related Achromatopsia: Pretreatment Characterization in Preparation of a Gene Replacement Therapy Trial

D Zobor, A Werner, F Stanzial… - … & visual science, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose The purpose of this study was to clinically characterize patients with CNGA3-linked
achromatopsia (CNGA3-ACHM) in preparation of a gene therapy trial. Methods Thirty-six …
[PDF] annettewerner.com

[PDF][PDF] The Clinical Phenotype of CNGA3-Related Achromatopsia: Pretreatment Characterization in Preparation of a Gene Replacement Therapy Trial

D Zobor, A Werner, F Stanzial, F Benedicenti… - 2017 - annettewerner.com
PURPOSE. The purpose of this study was to clinically characterize patients with CNGA3-
linked achromatopsia (CNGA3-ACHM) in preparation of a gene therapy trial. METHODS …
[HTML] arvojournals.org

[HTML][HTML] The Clinical Phenotype of CNGA3-Related Achromatopsia: Pretreatment Characterization in Preparation of a Gene Replacement Therapy Trial

D Zobor, A Werner, F Stanzial… - … & Visual Science, 2017 - jov.arvojournals.org
Purpose: The purpose of this study was to clinically characterize patients with CNGA3-linked
achromatopsia (CNGA3-ACHM) in preparation of a gene therapy trial. Methods: Thirty-six …
[PDF] semanticscholar.org

[PDF][PDF] The Clinical Phenotype of CNGA3-Related Achromatopsia: Pretreatment Characterization in Preparation of a Gene Replacement Therapy Trial

D Zobor, A Werner, F Stanzial, F Benedicenti… - 2017 - pdfs.semanticscholar.org
PURPOSE. The purpose of this study was to clinically characterize patients with CNGA3-
linked achromatopsia (CNGA3-ACHM) in preparation of a gene therapy trial. METHODS …

The Clinical Phenotype of CNGA3-Related Achromatopsia: Pretreatment Characterization in Preparation of a Gene Replacement Therapy Trial

D Zobor, A Werner, F Stanzial, F Benedicenti… - … & Visual Science, 2017 - hal.science
Purpose: The purpose of this study was to clinically characterize patients with CNGA3-linked
achromatopsia (CNGA3-ACHM) in preparation of a gene therapy trial. Methods: Thirty-six …

The clinical phenotype of CNGA3-related achromatopsia: Pretreatment characterization in preparation of a gene replacement therapy trial

D Zobor, A Werner, F Stanzial, F Benedicenti… - … and Visual Science, 2017 - lup.lub.lu.se
PURPOSE. The purpose of this study was to clinically characterize patients with CNGA3-
linked achromatopsia (CNGA3-ACHM) in preparation of a gene therapy trial. METHODS …
[PDF] academia.edu

[PDF][PDF] The Clinical Phenotype of CNGA3-Related Achromatopsia: Pretreatment Characterization in Preparation of a Gene Replacement Therapy Trial

D Zobor, A Werner, F Stanzial, F Benedicenti… - 2017 - academia.edu
PURPOSE. The purpose of this study was to clinically characterize patients with CNGA3-
linked achromatopsia (CNGA3-ACHM) in preparation of a gene therapy trial. METHODS …